Association of Topical Corticosteroids With Reduced Vulvar Squamous Cell Carcinoma Recurrence in Patients With Vulvar Lichen Sclerosus

被引：26
|
作者：
Chin, Simone [1 ,2 ,3 ]
Scurry, James [4 ,5 ]
Bradford, Jennifer [3 ]
Lee, Geoffrey [3 ]
Fischer, Gayle [3 ]
机构：
[1] Univ New South Wales, St Vincents Clin Sch, Victoria St, Darlinghurst, NSW 2010, Australia
[2] Royal Prince Alfred Hosp, Sydney, NSW, Australia
[3] Royal North Shore Hosp, Sydney, NSW, Australia
[4] John Hunter Hosp, New South Wales Hlth Pathol, Newcastle, NSW, Australia
[5] Univ Newcastle, Fac Hlth & Med, Newcastle, NSW, Australia
来源：
JAMA DERMATOLOGY | 2020年 / 156卷 / 07期
关键词：
RISK;
D O I：
10.1001/jamadermatol.2020.1074
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
This cohort study uses data from a medical record review of a dermatogynecology practice to describe the association between reduced recurrence of vulvar squamous cell carcinoma and use of topical corticosteroids in the treatment of vulvar lichen sclerosus.
引用
收藏
页码：813 / 814
页数：2
相关论文
共 50 条
  • [21] Treatment of vulvar lichen sclerosus with topical corticosteroids in children: a study of 72 children
    Casey, G. A.
    Cooper, S. M.
    Powell, J. J.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2015, 40 (03) : 289 - 292
  • [22] p53 expression in vulvar carcinoma, vulvar intraepithelial neoplasia, squamous cell hyperplasia and lichen sclerosus
    Hantschmann, P
    Sterzer, S
    Jeschke, U
    Friese, K
    [J]. ANTICANCER RESEARCH, 2005, 25 (3A) : 1739 - 1745
  • [23] RF - Importance of Topical Corticosteroid Treatment for Vulvar Lichen Sclerosus to Prevent Recurrences of Vulvar Carcinoma
    Luque-Luna, M.
    Bosch-Amate, X.
    Morgado-Carrasco, D.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2022, 113 (07): : 722 - 723
  • [24] Topical mometasone furoate for vulvar lichen sclerosus
    Cattaneo, A
    De Magnis, A
    Botti, E
    Sonni, L
    Carli, P
    Taddei, GL
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 2003, 48 (06) : 444 - 448
  • [25] Ultrapotent topical steroids for vulvar lichen sclerosus
    Ebell, M
    [J]. AMERICAN FAMILY PHYSICIAN, 2004, 70 (09) : 1768 - 1768
  • [26] Association of Vulvar Melanoma with Lichen Sclerosus
    Hieta, Niina
    Kurki, Samu
    Rintala, Marjut
    Soderlund, Jenni
    Hietanen, Sakari
    Orte, Katri
    [J]. ACTA DERMATO-VENEREOLOGICA, 2019, 99 (03) : 339 - 340
  • [27] Topical tacrolimus for recalcitrant vulvar lichen sclerosus
    Sotiriou, Eleni
    Apalla, Zoi
    Patsatsi, Aikaterini
    Panagiotidou, Despina
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2009, 19 (05) : 515 - 516
  • [28] Quality of Life in Vulvar Lichen Sclerosus Patients Treated With Long-Term Topical Corticosteroids
    Wijaya, Marlene
    Lee, Geoffrey
    Fischer, Gayle
    Lee, Andrew
    [J]. JOURNAL OF LOWER GENITAL TRACT DISEASE, 2021, 25 (02) : 158 - 165
  • [29] A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma
    Borghi, Alessandro
    D'Abundo, Lucilla
    Bassi, Cristian
    Lupini, Laura
    Tagliatti, Valentina
    Zedde, Pierantonia
    Lanza, Giovanni
    Gafa, Roberta
    Negrini, Massimo
    Corazza, Monica
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (05) : 680 - 681
  • [30] Topical Corticosteroids in the Treatment of Vulvar Lichen Sclerosus: A Review of Pharmacokinetics and Recommended Dosing Frequencies
    Mautz, Theodora T.
    Krapf, Jill M.
    Goldstein, Andrew T.
    [J]. SEXUAL MEDICINE REVIEWS, 2022, 10 (01) : 42 - 52
12345